Could this Tech Stock really climb 55.55% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Pharma Stock: 1,788% Upside?]( [Click Here for Symbol.]( --------------------------------------------------------------- March 28, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [FDA news shines light on this little-known clinical-stage Pharma]( Reader, This little-known clinical-stage pharma company recently received a favorable decision from the FDA and it's shining a light on its potential for significant growth. Could we be looking at 1,788% in upside potential? Free report reveals the name, ticker symbol, and 14 reasons to immediately start your research on this company. Don’t miss out on this one... [Click Here For Free Report]( --------------------------------------------------------------- [Cintas]( Symbol: [CTAS]( Recent Price: $440.68 Average Analyst Price Target: $525.00 (19.13%) Market Cap: $44.34B Last Year's EPS: $2.69 Consensus EPS Forecast: $3.04 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Ashish Sabadra, analyst at RBC Capital, reiterates coverage on [Cintas (CTAS)]( in the Services sector with a Buy rating and a price target of $525.00 (2 months ago). [TipRanks.com]( also reports that [Cintas]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $525.00. The target pricing ranges from a high forecast of $525.00 down to a low forecast of $525.00. [Cintas (CTAS)](’s last closing price was $440.68 which would put the average price target at 19.13% upside. Here are 3rd party ratings for [CTAS](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 7% (18 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Forever Battery: Making Gas Guzzlers Obsolete]( 2% of cars sold in the U.S. today are electric vehicles… but that’s about to change — FAST. A new battery breakthrough is ready to hit the market. It could revolutionize the $2 trillion automotive industry … and could soon make gas guzzlers obsolete. This technology is predicted to cause a 1,500% surge in electric vehicle sales over the next four years. The company pioneering this new battery could be the investment of a lifetime. [Click here for details.]( --------------------------------------------------------------- [Concentrix]( Symbol: [CNXC]( Recent Price: $120.61 Average Analyst Price Target: $165.00 (36.80%) Market Cap: $6.12B Last Year's EPS: $2.85 Consensus EPS Forecast: $2.6 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Vincent Colicchio, analyst at Barrington, reiterates coverage on [Concentrix (CNXC)]( in the Services sector with a Buy rating and a price target of $165.00 (1 week ago). [TipRanks.com]( also reports that [Concentrix]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $165.00. The target pricing ranges from a high forecast of $165.00 down to a low forecast of $165.00. [Concentrix (CNXC)](’s last closing price was $120.61 which would put the average price target at 36.80% upside. Here are 3rd party ratings for [CNXC](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 6% (16 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Paychex]( Symbol: [PAYX]( Recent Price: $109.08 Average Analyst Price Target: $111.67 (2.37%) Market Cap: $39.23B Last Year's EPS: $1.15 Consensus EPS Forecast: $1.25 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Ramsey El, analyst at Barclays, reiterates coverage on [Paychex (PAYX)]( in the Technology sector with a Sell rating and a price target of $105.00 (2 weeks ago). [TipRanks.com]( also reports that [Paychex]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Sell rating with an average price target is $111.67. The target pricing ranges from a high forecast of $116.00 down to a low forecast of $105.00. [Paychex (PAYX)](’s last closing price was $109.08 which would put the average price target at 2.37% upside. Here are 3rd party ratings for [PAYX](: - TipRanks.com: Moderate Sell - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 18% (44 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [RH]( Symbol: [RH]( Recent Price: $241.01 Average Analyst Price Target: $330.00 (36.92%) Market Cap: $5.79B Last Year's EPS: $5.66 Consensus EPS Forecast: $3.32 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Joe Feldman, analyst at Telsey Advisory, reiterates coverage on [RH (RH)]( in the Consumer Goods sector with a Hold rating and a price target of $280.00 (3 days ago). [TipRanks.com]( also reports that [RH]( currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $330.00. The target pricing ranges from a high forecast of $385.00 down to a low forecast of $280.00. [RH (RH)](’s last closing price was $241.01 which would put the average price target at 36.92% upside. Here are 3rd party ratings for [RH](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 34% (169 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [UniFirst]( Symbol: [UNF]( Recent Price: $191.82 Average Analyst Price Target: $192.50 (0.35%) Market Cap: $3.42B Last Year's EPS: $1.24 Consensus EPS Forecast: $1.38 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Andrew Steinerman, analyst at J.P. Morgan, reiterates coverage on [UniFirst (UNF)]( in the Services sector with a Sell rating and a price target of $160.00 (2 months ago). [TipRanks.com]( also reports that [UniFirst]( currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $192.50. The target pricing ranges from a high forecast of $225.00 down to a low forecast of $160.00. [UniFirst (UNF)](’s last closing price was $191.82 which would put the average price target at 0.35% upside. Here are 3rd party ratings for [UNF](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 7% (18 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The #1 Stock Under $5]( Stock-Picking Millionaire Says It’s Not About Diversification! Buy one single $3 stock- that trades under a secret name- and it could help make your retirement. [His instructions are here.]( --------------------------------------------------------------- [Verint Systems]( Symbol: [VRNT]( Recent Price: $36.87 Average Analyst Price Target: $40.00 (8.49%) Market Cap: $2.38B Last Year's EPS: $0.57 Consensus EPS Forecast: $0.72 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Samad Samana, analyst at Jefferies, reiterates coverage on [Verint Systems (VRNT)]( in the Technology sector with a Hold rating and a price target of $40.00 (2 months ago). [TipRanks.com]( also reports that [Verint Systems]( currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $40.00. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $40.00. [Verint Systems (VRNT)](’s last closing price was $36.87 which would put the average price target at 8.49% upside. Here are 3rd party ratings for [VRNT](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 29% (73 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Semtech]( Symbol: [SMTC]( Recent Price: $31.18 Average Analyst Price Target: $48.50 (55.55%) Market Cap: $2.03B Last Year's EPS: $0.7 Consensus EPS Forecast: $0.48 Expected Earnings Date: Mar 29 2023 Recent Analyst Action: Craig Ellis, analyst at B.Riley Financial, reiterates coverage on [Semtech (SMTC)]( in the Technology sector with a Buy rating and a price target of $52.00 (6 days ago). [TipRanks.com]( also reports that [Semtech]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $48.50. The target pricing ranges from a high forecast of $62.00 down to a low forecast of $32.00. [Semtech (SMTC)](’s last closing price was $31.18 which would put the average price target at 55.55% upside. Here are 3rd party ratings for [SMTC](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Top 32% (80 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [FDA News: The 1,788% Catalyst?]( Recent FDA News Propel This Little-Known Pharma Stock 1,788% in Early 2023? --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software